Agios Moves Closer to Fast FDA Approval for New Sickle Cell Pill

Agios is pursuing accelerated FDA approval for mitapivat, a new oral pill for sickle cell disease. The RISE UP trial showed better hemoglobin levels, fewer pain crises, and good safety.